cGMP Certification in the USA
Independent, third-party cGMP certification for US manufacturers — scoped to your product category, audited against the applicable GMP/cGMP scheme, and backed by a fixed written quotation. It sits alongside your FDA obligations, never in place of them.
Ready to scope your certification? Send your product categories and receive a fixed written quotation — contact IAS today.
At a Glance
- Scope: audited against the scheme that governs your product category rather than a general-purpose checklist.
- Eligible industries: from drug plants and supplement makers to food processors, cosmetic houses and device manufacturers; no category is excluded.
- Certification cycle: initial audit, certificate issuance, annual surveillance, then recertification.
- Pricing: one written quotation after scoping, fixed from that point — no published flat rate, no surprise charges.
- Relationship to the FDA: independent and voluntary — IAS certifies; the FDA regulates. Neither replaces the other.
The Most Common Misunderstanding About cGMP Certification in the USA
An IAS cGMP certificate is independent, third-party evidence that a facility’s manufacturing controls have been assessed against a defined GMP/cGMP scheme. It is not an FDA credential, not FDA approval, and not FDA registration. The FDA does not issue, endorse, co-sign, or in any way authorize any certification body’s certificate.
- Why the confusion happens — the word “cGMP” appears throughout FDA regulations, so it is natural to assume a cGMP certificate is something the FDA certification and compliance pathway itself produces. It does not.
- How the FDA actually regulates — facility registration, routine and for-cause inspections, Form 483 observations, warning letters, import alerts, and product-specific pathways such as NDA/ANDA approval for drugs or 510(k) clearance for devices. None of these mechanisms involve the FDA appointing or authorizing outside organizations to issue “FDA-approved” certificates — because no such thing exists.
- What IAS certification actually is — a voluntary commercial assessment from IAS, giving customers, distributors, auditors, and business partners an independently verified snapshot of a facility’s quality-management discipline, assessed against the specific GMP/cGMP scheme and scope named on the certificate.
Treat any supplier, consultant or marketing claim that an IAS certificate substitutes for FDA registration, clearance or approval as inaccurate, and correct it immediately.
cGMP Meaning: GMP vs cGMP, Same Root, Different Emphasis
GMP (Good Manufacturing Practice) is the broad, generic term for quality-control principles in production. cGMP (current Good Manufacturing Practice) is the US regulatory phrasing. It emphasizes that manufacturers must keep pace with currently accepted methods, equipment, and controls, not practices frozen at whatever standard applied years ago.
- The “c” is not decorative. It signals an expectation that quality systems, equipment, and technology are kept current with evolving industry practice and FDA guidance.
- A US-specific term. cGMP belongs mainly to 21 CFR, while GMP travels more widely, appearing in WHO guidelines and other national codes.
- Not one universal standard. The label “cGMP” shows up across several distinct frameworks. That is why every IAS certificate names the specific scheme and scope the audit covered, instead of making a generic cGMP claim.
- Certification stays current, too. Requirements evolve, so a facility that complied three audit cycles ago does not automatically comply today. That is why surveillance continues through the cycle rather than stopping at the first certificate.
Who Regulates What: FDA, State Agencies, WHO, and IAS
Conversation often collapses four distinct actors into one. Each has a separate remit, and none of them substitutes for another:
| Body | Actual role | What it does NOT do |
|---|---|---|
| US FDA | Federal regulator for drugs (21 CFR 210–211), dietary supplements (21 CFR 111), and food (21 CFR 117); registers facilities, conducts inspections, issues Form 483s and warning letters, approves drug applications and device clearances. | Does not issue, license, endorse, or co-brand any third-party GMP/cGMP certificate. |
| State health, agriculture & pharmacy boards | License and inspect within their own state remit — state food-processing licenses, state boards of pharmacy, intrastate manufacturing permits — alongside, not instead of, federal FDA oversight. | Does not replace FDA jurisdiction over interstate commerce, and does not itself certify to a cGMP scheme. |
| World Health Organization (WHO) | Publishes GMP guidance documents and technical reports used as reference material by manufacturers and regulators internationally. | Is not a regulator, does not inspect US facilities, and does not certify or accredit anyone. |
| IAS | Independent third-party body that audits a facility against the applicable GMP/cGMP scheme and defined scope, and issues certification under its UQAS accreditation. | Is not a government agency; cannot grant market authorization, product approval, or regulatory clearance of any kind. |
The practical takeaway: FDA compliance is a legal obligation tied to what you manufacture and sell in the US market; IAS certification is a separate, voluntary layer of independent verification that complements those obligations — useful for customers, export partners, and internal governance, but never a substitute for meeting FDA requirements.
cGMP Certification in the USA: What an Audit Typically Looks At
Because the applicable scheme and product category vary, the areas an auditor examines vary too. In general, a cGMP-related assessment typically covers areas such as:
- Facility layout, environmental controls, and contamination-prevention measures
- Equipment qualification, calibration, and preventive maintenance records
- Personnel training, hygiene practices, and documented competency
- Production and process controls, including in-process checks
- Quality control testing, sampling, and product release procedures
- Documentation practices and record-keeping integrity
- Complaint handling, deviation management, and recall readiness
- Supplier qualification and incoming material controls
These are areas typically assessed, depending on the applicable scheme and product category — not a universal checklist that applies identically to every applicant. The site’s own cGMP internal auditor training in the USA is what keeps these areas under review between external assessments.
Not One Framework: cGMP Requirements Referenced Differently by Product Category
Food, dietary supplements, pharmaceuticals, cosmetics, and medical devices do not share one identical cGMP rulebook. In the US market, the frameworks commonly referenced include:
| Product category | Framework(s) commonly referenced |
|---|---|
| Pharmaceuticals | 21 CFR Parts 210–211 (finished pharmaceuticals) |
| Dietary supplements | 21 CFR Part 111 |
| Food manufacturing | 21 CFR Part 117 / FSMA preventive controls, with HACCP principles frequently referenced for specific lines |
| Medical devices | Quality-system expectations typically referenced via ISO 13485 rather than a distinct FDA cGMP device rule |
| Cosmetics | Voluntary in the US; ISO 22716 is the framework most commonly referenced |
| Export-facing operations | May also reference WHO GMP guidelines or the PIC/S GMP guide, depending on the destination market |
Food-line manufacturers can pair this with HACCP certification or ISO 22000 food safety certification as complementary schemes.
cGMP certification is also not limited to these five categories. Packaging manufacturers, chemical producers, animal feed producers, contract packagers and co-packers, and warehousing/logistics providers handling regulated goods can all pursue GMP-scoped certification for their own products and processes. It is open to any industry willing to be assessed against a defined, applicable scheme.
Not sure which scheme applies to your products? Ask for a free scoping conversation.
The IAS cGMP Certification Pathway
While details vary by scheme and scope, the pathway generally follows this sequence:
- Inquiry and scope definition — confirming which product category, sites, and scheme(s) apply.
- Application and documentation review — evaluating existing quality manuals, SOPs, and records against the applicable scheme.
- On-site (or remote, where applicable) assessment — auditors examine the areas relevant to the confirmed scope.
- Corrective action closure — addressing any nonconformities identified during the assessment.
- Certification decision and issuance — an independent technical review precedes the certificate.
For a fuller breakdown of how IAS structures assessments generally, see the certification process overview and the cGMP certification audit procedure page.
Certification Lifecycle: Staying Current After You Are Certified
Because “current” is the operative word in cGMP, certification is not a one-time event. It is maintained on a cycle:
- Initial audit — the assessment that leads to first certification.
- Certificate issued — scoped to the specific scheme, sites, and product categories audited.
- Annual surveillance — periodic checks that the quality system remains effective between full reassessments.
- Recertification audit — a fuller reassessment before the certificate’s validity period ends, restarting the cycle.
Any change to product lines, sites or processes outside the original scope usually calls for a scope extension or reassessment. The certificate only ever speaks to what the audit actually covered.
cGMP Certification Cost in the USA: What Shapes Cost and Duration
IAS does not publish fixed prices or fixed week/month timelines for cGMP certification in the USA, because both depend heavily on facility-specific factors. Instead, every applicant receives a fixed written quotation once scope is confirmed. The main determinants are:
- Facility size, number of production lines, and number of sites in scope
- Which product category and scheme(s) apply, and how broad the certification scope is
- How mature existing documentation, training records, and quality controls already are
- Volume and complexity of any corrective actions required after assessment
- Whether multiple sites or a group/multi-site certification arrangement is involved
- Auditor availability and how quickly the applicant closes out findings
IAS does not estimate a duration in weeks or months. It frames timeline around facility readiness and how quickly documentation and corrective actions can be finalized. That is why the lifecycle above, not a fixed calendar, is the more reliable way to think about pacing.
Want a real number, not a range? Request your fixed written quotation on 1 (888) 493-0916.
Documentation Commonly Referenced During Assessment
As applicable to the certification scheme and product category, auditors may reference records such as:
| Document / record type | Typical purpose (as applicable) |
|---|---|
| Quality manual / quality policy | States the facility’s overall approach to quality management and the scope of the system |
| Standard operating procedures (SOPs) | Define how production, cleaning, and maintenance activities are consistently carried out |
| Batch / production records | Document what was actually produced, by whom, and under what conditions |
| CAPA (corrective and preventive action) records | Track how identified issues are investigated, resolved, and prevented from recurring |
| Change control records | Show that changes to process, equipment, or materials are evaluated before implementation |
| Equipment qualification & calibration logs | Demonstrate equipment is fit for purpose and measurement is reliable |
| Validation records (process, cleaning, or method) | Provide evidence that a process consistently produces the intended result |
| Data integrity controls & audit trails | Support that records are attributable, accurate, and unaltered |
None of these are universally mandatory documents — which records apply, and how deeply each is examined, depends on the scheme and scope named on the certificate application.
Why US Manufacturers Pursue cGMP Certification Beyond the Factory Floor
US manufacturers rarely sell only domestically. Pharmaceutical ingredient suppliers, dietary supplement contract manufacturers, specialty food producers, and cosmetics formulators frequently ship into export markets where buyers evaluate quality systems differently than FDA registration alone communicates. Independent certification also supports the system certification programs already in place at multi-site operations. Typical contexts where this comes up:
| Buyer / market context | Why independent cGMP evidence gets requested |
|---|---|
| International distributors and importers | Overseas retailers or health authorities may not directly recognize US FDA registration as a stand-alone quality-system credential and ask for independent verification instead |
| Contract manufacturing (CMO/CPO) clients | Brand owners auditing a contract manufacturer often want independent confirmation of consistent process control, separate from their own supplier audits |
| Large retail and pharmacy chain vendor programs | Vendor qualification checklists at national retail and pharmacy chains frequently list third-party GMP certification as a preferred or required criterion |
| Government or institutional tenders abroad | Procurement bid criteria in some export markets specify recognized GMP certification as a qualifying document |
| Investor and M&A due diligence | Buyers and investors assessing manufacturing risk often treat certification status as one data point among several in evaluating operational maturity |
What Independent Certification Adds Beyond FDA Compliance
FDA compliance establishes the legal floor for operating in the US market. Independent cGMP certification in the USA sits above that floor as a separate, portable form of assurance. Facilities that go through the process typically report a few recurring advantages rather than a fixed return-on-investment figure:
- An externally validated reference point that customers, distributors, and auditors can check without arranging their own on-site supplier audit.
- Greater internal discipline around documentation, change control, and corrective action tracking, since these are examined on a recurring surveillance cycle rather than only during an FDA inspection window.
- A portable credential that travels with the business across new customer relationships, new markets, and new retail or distribution partnerships, rather than being tied to a single buyer’s private audit.
- A consistent onboarding framework for new sites or product lines, since scope extensions follow the same assessment logic as the original certification.
None of this changes what the FDA requires of a facility. It gives the business an additional, independently verified way to demonstrate that its manufacturing controls are being maintained consistently over time. That is often what a commercial partner, rather than a regulator, is asking to see.
Quick Definitions
- GMP: Good Manufacturing Practice — the broad term for manufacturing quality requirements.
- cGMP: current Good Manufacturing Practice — the US regulatory phrasing emphasizing that quality systems stay current with evolving practice.
- Scheme and scope: the framework used as the benchmark and the product range it covers, set at application.
- Surveillance audit: an abbreviated annual assessment verifying the certified system remains in place.
- Recertification: the full reassessment conducted at the end of the certification cycle.
Take the Next Step Toward cGMP Certification
If you manufacture pharmaceuticals, dietary supplements, food, cosmetics, medical devices, or any other product line where customers or export partners expect independent evidence of manufacturing controls, call 1 (888) 493-0916 to discuss scope and receive a fixed written quotation.
- No obligation to proceed after scoping
- Written quotation covers the full cycle, surveillance included
- Related paths worth reviewing: ISO 9001 certification for broader quality management, and ISO 13485 certification for medical device manufacturers
Get started: call 1 (888) 493-0916 · download the application form · download the cGMP brochure
Further reading: the IAS blog on how to get ISO certification, and the IAS online privacy statement for how inquiries are handled.
Frequently Asked Questions
Does an IAS cGMP certificate mean the FDA has approved my facility or products?
No. An IAS cGMP certificate is independent third-party certification, not FDA approval, registration, or clearance. The FDA does not issue or endorse third-party certificates, so certification and FDA compliance are separate, complementary things that both need to be maintained.
Is cGMP certification legally required to sell products in the United States?
cGMP certification in the USA is not itself a legal precondition for selling in the US — that depends on your FDA registration and product-category obligations. Certification is a voluntary, additional layer that many manufacturers pursue for customer, retailer, or export requirements.
We already meet FDA cGMP regulations — why pursue third-party certification as well?
FDA compliance and third-party certification serve different audiences. Certification gives customers, distributors, and business partners an independently verified reference point they can check without arranging their own supplier audit, which regulatory compliance alone does not provide.
Can a company outside food, pharma, cosmetics, or medical devices get cGMP certified?
Yes. Certification is open to any industry willing to be assessed against an applicable, clearly scoped GMP/cGMP scheme — packaging manufacturers, chemical producers, animal feed producers, contract packagers, and warehousing operations can all apply.
Does cGMP certification help when exporting outside the United States?
It can. Export buyers, distributors, and some international procurement processes often request independent GMP evidence alongside domestic regulatory registration, since they may not otherwise have visibility into a US facility’s quality system.
Do individual US states have their own GMP-related requirements alongside the FDA?
Many states run their own licensing through health, agriculture, or pharmacy boards for activities within that state, operating alongside federal FDA oversight rather than replacing it. Certification scope should reflect any state-level context relevant to the facility.
What happens to my certificate if the FDA later conducts its own inspection?
The two are independent. An FDA inspection assesses regulatory compliance under its own authority and can proceed regardless of certification status; the IAS certificate itself remains subject to its own surveillance and recertification cycle.
How long does a cGMP certificate stay valid, and how does surveillance work?
Validity is tied to the certification cycle: an initial audit and issuance, followed by periodic annual surveillance, and a fuller recertification audit before the cycle repeats. Specific validity terms are stated on the certificate itself. More questions are answered on the cGMP certification frequently asked questions page.